Irrespective of the precise underlying molecular mechanisms, both studies emphasize the importance of the anticoagulant protein C pathway in disease progression of IPF and the availability of endogenous APC may thus be an important clinical and pharmacological parameter in patients with IPF. Here, APC is linked to idiopathic pulmonary fibrosis.